Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    24382002 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Study on the microRNA Expression Level in Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis
Intervention: Other: osteoporosis
2 Completed Phase 2 Study of AMG 785 in Postmenopausal Women With Low Bone Mineral Density
Conditions: Low Bone Mineral Density;   Postmenopausal Osteoporosis
Interventions: Drug: Active Comparator Alendronate;   Drug: Placebo;   Drug: AMG 785;   Drug: Active comparator teriparatide;   Drug: Denosumab;   Drug: Zoledronic acid

Study has passed its completion date and status has not been verified in more than two years.